- cafead   Jan 08, 2024 at 12:22: PM
via Regeneron hopes its longer-lasting Eylea formulation, Eylea HD, can build on the success of the company's original blockbuster product. With $123 million in sales during Eylea HD's first quarter on the market, the eye med is showing early indicators of broad initial uptake, CEO Leonard Schleifer, M.D., Ph.D., said in a corporate update. But overall Q4 Eylea sales, at $1.46 billion, missed analyst expectations of $1.49 billion to $1.56 billion, according to Piper Sandler analyst Christopher Raymond.
article source
article source